ADVERTISEMENT
Podcasts
George Karpouzas, MD, on the Biomarkers for Predicting Coronary Atherosclerosis in RA
05/28/2020
In this podcast, George Karpouzas, MD, talks about his research on highly sensitive cardiac troponin-I and IgA antibodies against β-2 glycoprotein 1 in the setting of coronary atherosclerosis among patients with rheumatoid arthritis. Read the transcript here.
Additional Resource:
- Karpouzas GA, Ormseth SR, Hernandez E, Budoff MJ. Highly-sensitive cardiac troponin-I and beta-2-glycoprotein-I IgA antibodies inform the utility of screening and follow-up non-invasive coronary atherosclerosis evaluation and optimize cardiovascular risk assessment in rheumatoid arthritis. Paper presented at: American College of Rheumatology 2019; Atlanta, GA; November 8-11, 2019. https://acrabstracts.org/abstract/highly-sensitive-cardiac-troponin-i-and-beta-2-glycoprotein-i-iga-antibodies-inform-the-utility-of-screening-and-follow-up-non-invasive-coronary-atherosclerosis-evaluation-and-optimize-cardiovascular/
George A. Karpouzas, MD, is a professor of medicine at the University of California, Los Angeles, and chief of rheumatology at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in Los Angeles, California.